(1)
Bio Studies of Novel Macrocyclic Sulfazan and Linear Sulfazan (Creation, Analysis and Anticancer Assessment). Journal of Pharmaceutical Negative Results 2022, 13 (4), 351-363. https://doi.org/10.47750/pnr.2022.13.04.043.